Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,440,647 papers from all fields of science
Search
Sign In
Create Free Account
Lilly A 217
Known as:
Lilly-A-217
, LY A 217
, Lilly A-217
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Carboxylic Acids
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
LB0002 RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE, PHASE 2B STUDY TO DEMONSTRATE THE SAFETY AND EFFICACY OF TILDRAKIZUMAB, A HIGH-AFFINITY ANTI-INTERLEUKIN-23P19 MONOCLONAL ANTIBODY…
P. Mease
,
S. Chohan
,
+4 authors
M. Luggen
Oral Presentations
2019
Corpus ID: 196574881
Background Tildrakizumab (TIL), a high-affinity anti–interleukin-23p19 monoclonal antibody, is approved for moderate-to-severe…
Expand
Review
2017
Review
2017
Role of cortical bone in hip fracture.
J. Reeve
BoneKEy Reports
2017
Corpus ID: 2203408
In this review, I consider the varied mechanisms in cortical bone that help preserve its integrity and how they deteriorate with…
Expand
2016
2016
Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
P. Capranzano
,
D. Capodanno
,
+9 authors
C. Tamburino
European heart journal. Acute cardiovascular care
2016
Corpus ID: 2979090
Aim: Whether high platelet reactivity (HPR) immediately after diagnostic angiography is associated with worse coronary…
Expand
Review
2012
Review
2012
The validity of self-rated psychotic symptoms in depressed inpatients
Florian Seemüller
,
Michael Riedel
,
+14 authors
H. Möller
European psychiatry
2012
Corpus ID: 13114351
2011
2011
Bleeding Risk Comparing Targeted Low-Dose Heparin With Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: Results From a Propensity Score–Matched Analysis of the Evaluation of…
S. Bangalore
,
D. Cohen
,
+4 authors
L. Mauri
Circulation. Cardiovascular Interventions
2011
Corpus ID: 23467040
Background— Prior randomized trials have shown reduced bleeding with bivalirudin compared with unfractionated heparin (UFH) in…
Expand
2010
2010
Transradial approach in patients with ST-elevation myocardial infarction treated with abciximab results in fewer bleeding complications: data from EUROTRANSFER registry
Z. Siudak
,
B. Zawiślak
,
+7 authors
D. Dudek
Coronary Artery Disease
2010
Corpus ID: 9099025
ObjectivesOur aim was to investigate the safety and efficacy of transradial approach, predictors of bleeding complications, and…
Expand
Review
2009
Review
2009
Contributing factors to weight gain during long‐term treatment with second‐generation antipsychotics. A systematic appraisal and clinical implications
S. Gentile
,
A. Salerno
Obesity Reviews
2009
Corpus ID: 3456269
The increased rates of both overweight and obesity reported in severely mentally‐ill patients are prevalently due to the use of…
Expand
2009
2009
The Evolving Application of the Written Description Requirement to Biotechnological Inventions
Janice M. Mueller
2009
Corpus ID: 53575536
A United States patent must provide a "written description" of the invention claimed therein. In its earliest implementation, a…
Expand
Review
2008
Review
2008
Diagnosis and treatment in the early illness phase of bipolar disorders
M. Bauer
,
G. Juckel
,
C. Correll
,
K. Leopold
,
A. Pfennig
European Archives of Psychiatry and Clinical…
2008
Corpus ID: 529703
The combination of a long undetected illness and significant psychosocial impairment renders early identification and…
Expand
2001
2001
Dark clouds over Toronto psychiatry research
K. Birmingham
Nature Network Boston
2001
Corpus ID: 42581896
The University of Toronto (UT) and its affiliated hospitals have become embroiled in another controversy regarding their attitude…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE